Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 1;31(9):2429-2437.
doi: 10.1093/ibd/izaf054.

Health Outcomes, Discrimination, and Stigma Among Sexual and Gender Minority People With Inflammatory Bowel Disease

Affiliations

Health Outcomes, Discrimination, and Stigma Among Sexual and Gender Minority People With Inflammatory Bowel Disease

Kira L Newman et al. Inflamm Bowel Dis. .

Abstract

Background: Sexual and gender minority (SGM) individuals often experience more discrimination and worse health than non-SGM people. Less is known about SGM individuals with inflammatory bowel disease (IBD). We studied IBD outcomes, discrimination, illness-related stigma, and SGM status in a cross-sectional survey.

Methods: In total, 1586 IBD Partners e-cohort participants self-reported sexual orientation, gender identity, and prior IBD treatment. They completed the Short Crohn's Disease Activity Index or Simple Clinical Colitis Activity Index, the Everyday Discrimination Scale, and the Paradox of Self Stigma (PASS-24) scale. We performed regression analyses controlling for age, race, disease duration, and IBD type.

Results: SGM people were 7.8% (n = 124) of the cohort. SGM participants were younger than non-SGM participants (median age 40 vs. 54 years, P < .001). Among SGM individuals, 67% (n = 74) were in remission based on disease activity scores. Among non-SGM individuals, 74% (n = 936) were in remission (P = .097). Similar proportions of SGM and non-SGM persons reported prior IBD-related hospitalization (40% vs. 37%, P = .426; adjusted odds ratio [aOR] 0.95, 95% confidence interval [CI], 0.62-1.45) and IBD-related surgery (52% vs. 54%, P = .707, aOR 1.25, 95% CI, 0.81-1.94). SGM respondents reported more discrimination (71% vs. 47%, P < .001), and 43% of SGM individuals reported healthcare-related discrimination versus 21% of non-SGM individuals (P < .001). SGM persons also endorsed more internalized stigma (median PASS-24 scores 53 vs. 47, P = .026).

Conclusions: SGM individuals with IBD are more likely to experience discrimination, including in healthcare, and illness-related stigma. These may significantly impact the quality of life and should be considered in the care of SGM people with IBD.

Keywords: Crohn’s disease; LGBTQ; health disparities; patient-reported outcomes; ulcerative colitis.

Plain language summary

In a national survey, we found that sexual and gender minority (SGM) individuals with inflammatory bowel disease are more likely to experience discrimination, including in healthcare, and illness-related stigma than non-SGM individuals.

PubMed Disclaimer

Conflict of interest statement

K.L.N.: grant funding for registry development from Pfizer. PDRH: Consultant for AbbVie, Buhlmann Labs, Celltrion, Curacle, Eli Lilly; advisor for GI Health Foundation. M.D.L.: Consulting for Takeda, Pfizer, Janssen, AbbVie, BMS, Lilly, Intercept, Target RWE, Prometheus, Research support: Takeda, Pfizer, Lilly. P.A.W.: none.

Comment in

References

    1. Jones JM. U.S. LGBT identification steady at 7.2%. Gallup. 2023. Accessed March 12, 2025. https://news.gallup.com/poll/470708/lgbt-identification-steady.aspx
    1. Mpofu JJ, Underwood JM, Thornton JE, et al. Overview and Methods for the Youth Risk Behavior Surveillance System - United States, 2021. MMWR Suppl. 2023;72(1):1-12. - PMC - PubMed
    1. Fish JN, Turpin RE, Williams ND, Boekeloo BO. Sexual identity differences in access to and satisfaction with health care: findings from nationally representative data. Am J Epidemiol. 2021;190(7):1281-1293. doi: https://doi.org/ 10.1093/aje/kwab012 - DOI - PMC - PubMed
    1. Flentje A, Heck NC, Brennan JM, Meyer IH. The relationship between minority stress and biological outcomes: a systematic review. J Behav Med. 2020;43(5):673-694. doi: https://doi.org/ 10.1007/s10865-019-00120-6 - DOI - PMC - PubMed
    1. Newman KL, Velez C, Paul S, Radix AE, Streed CG, Targownik LE. Research considerations in digestive and liver disease in transgender and gender-diverse populations. Clin Gastroenterol Hepatol. 2023;21(10):2443-2449.e2. doi: https://doi.org/ 10.1016/j.cgh.2023.06.008 - DOI - PMC - PubMed

LinkOut - more resources